ACCESSION: MSBNK-SMB_Measured-HSA001P0112011
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 120
COMMENT: RAW_SPEC {'19_posi_10876': {'bp': 121680.0, 'sum': 338891.0}, '11_posi_10578': {'bp': 105524.0, 'sum': 302896.0}, '19_posi_10411': {'bp': 108377.0, 'sum': 303949.0}, '17_posi_10517': {'bp': 110648.0, 'sum': 324585.0}, '17_posi_10874': {'bp': 88663.0, 'sum': 284241.0}, '9_posi_10499': {'bp': 97566.0, 'sum': 296526.0}, '9_posi_10581': {'bp': 99005.0, 'sum': 309014.0}, '13_posi_10517': {'bp': 99034.0, 'sum': 308044.0}, '9_posi_10896': {'bp': 103267.0, 'sum': 309133.0}, '17_posi_10602': {'bp': 104222.0, 'sum': 303757.0}, '9_posi_10393': {'bp': 94614.0, 'sum': 280219.0}, '15_posi_10687': {'bp': 103528.0, 'sum': 311060.0}, '8_posi_10960': {'bp': 101430.0, 'sum': 285245.0}, '13_posi_10813': {'bp': 95876.0, 'sum': 300660.0}, '14_posi_10961': {'bp': 99465.0, 'sum': 294291.0}, '3_posi_10918': {'bp': 95155.0, 'sum': 279394.0}, '8_posi_10832': {'bp': 92800.0, 'sum': 293560.0}, '15_posi_10562': {'bp': 102166.0, 'sum': 316284.0}, '12_posi_10728': {'bp': 97899.0, 'sum': 293619.0}, '6_posi_10414': {'bp': 95491.0, 'sum': 301424.0}, '17_posi_10791': {'bp': 89217.0, 'sum': 270070.0}, '11_posi_10854': {'bp': 89099.0, 'sum': 256907.0}, '10_posi_10793': {'bp': 88423.0, 'sum': 277986.0}, '11_posi_10750': {'bp': 87358.0, 'sum': 268534.0}, '16_posi_10854': {'bp': 117132.0, 'sum': 340688.0}, '10_posi_10708': {'bp': 102310.0, 'sum': 275341.0}, '5_posi_10644': {'bp': 100779.0, 'sum': 285035.0}, '16_posi_10688': {'bp': 100665.0, 'sum': 275237.0}, '1_posi_10812': {'bp': 100342.0, 'sum': 292557.0}, '10_posi_10519': {'bp': 95496.0, 'sum': 296151.0}, '11_posi_10415': {'bp': 86533.0, 'sum': 287465.0}, '15_posi_10897': {'bp': 86364.0, 'sum': 276670.0}, '7_posi_10393': {'bp': 110643.0, 'sum': 330962.0}, '10_posi_10603': {'bp': 106820.0, 'sum': 306181.0}, '19_posi_10583': {'bp': 102737.0, 'sum': 307514.0}, '13_posi_10686': {'bp': 96897.0, 'sum': 313662.0}, '8_posi_10604': {'bp': 95938.0, 'sum': 281699.0}, '5_posi_10477': {'bp': 95640.0, 'sum': 288674.0}, '1_posi_10688': {'bp': 87777.0, 'sum': 301436.0}, '12_posi_10897': {'bp': 86900.0, 'sum': 283405.0}, '4_posi_10518': {'bp': 84595.0, 'sum': 264491.0}, '17_posi_10687': {'bp': 110562.0, 'sum': 338241.0}, '8_posi_10519': {'bp': 101016.0, 'sum': 302963.0}, '9_posi_10813': {'bp': 96974.0, 'sum': 300131.0}, '4_posi_10709': {'bp': 96904.0, 'sum': 299731.0}, '14_posi_10452': {'bp': 96255.0, 'sum': 302316.0}, '13_posi_10919': {'bp': 95682.0, 'sum': 288162.0}, '14_posi_10709': {'bp': 94987.0, 'sum': 280191.0}, '5_posi_10730': {'bp': 94805.0, 'sum': 280824.0}, '3_posi_10496': {'bp': 93348.0, 'sum': 311177.0}, '10_posi_10436': {'bp': 92700.0, 'sum': 282368.0}, '4_posi_10625': {'bp': 92504.0, 'sum': 288326.0}, '4_posi_10960': {'bp': 91931.0, 'sum': 283772.0}, '8_posi_10435': {'bp': 87304.0, 'sum': 271218.0}, '6_posi_10603': {'bp': 86161.0, 'sum': 270926.0}, '16_posi_10494': {'bp': 120024.0, 'sum': 336532.0}, '18_posi_10541': {'bp': 108594.0, 'sum': 342868.0}, '15_posi_10475': {'bp': 108041.0, 'sum': 315690.0}, '8_posi_10688': {'bp': 106533.0, 'sum': 315095.0}, '3_posi_10791': {'bp': 100944.0, 'sum': 314925.0}, '7_posi_10814': {'bp': 100764.0, 'sum': 290595.0}, '15_posi_10394': {'bp': 98830.0, 'sum': 270742.0}, '2_posi_10456': {'bp': 98191.0, 'sum': 311375.0}, '6_posi_10855': {'bp': 96148.0, 'sum': 279525.0}, '12_posi_10414': {'bp': 92831.0, 'sum': 291138.0}, '18_posi_10835': {'bp': 91343.0, 'sum': 294671.0}, '11_posi_10662': {'bp': 89696.0, 'sum': 289172.0}, '10_posi_10939': {'bp': 85257.0, 'sum': 290316.0}, '11_posi_10937': {'bp': 84987.0, 'sum': 280336.0}, '5_posi_10835': {'bp': 84979.0, 'sum': 254383.0}, '5_posi_10561': {'bp': 79903.0, 'sum': 256434.0}, '13_posi_10414': {'bp': 114986.0, 'sum': 327705.0}, '7_posi_10477': {'bp': 99600.0, 'sum': 291926.0}, '16_posi_10771': {'bp': 96112.0, 'sum': 289177.0}, '16_posi_10940': {'bp': 93215.0, 'sum': 273558.0}, '3_posi_10667': {'bp': 88521.0, 'sum': 263620.0}, '7_posi_10894': {'bp': 88338.0, 'sum': 277065.0}, '11_posi_10496': {'bp': 116473.0, 'sum': 349158.0}, '18_posi_10625': {'bp': 115551.0, 'sum': 328231.0}, '18_posi_10392': {'bp': 101240.0, 'sum': 311594.0}, '14_posi_10537': {'bp': 99815.0, 'sum': 317066.0}, '7_posi_10562': {'bp': 96920.0, 'sum': 282441.0}, '2_posi_10603': {'bp': 96618.0, 'sum': 296050.0}, '16_posi_10583': {'bp': 95005.0, 'sum': 298082.0}, '3_posi_10415': {'bp': 94255.0, 'sum': 315450.0}, '6_posi_10772': {'bp': 103189.0, 'sum': 304102.0}, '4_posi_10877': {'bp': 102336.0, 'sum': 303472.0}, '6_posi_10498': {'bp': 93198.0, 'sum': 267800.0}, '19_posi_10959': {'bp': 91543.0, 'sum': 283874.0}, '12_posi_10621': {'bp': 117963.0, 'sum': 346358.0}, '15_posi_10772': {'bp': 106743.0, 'sum': 321003.0}, '17_posi_10433': {'bp': 105557.0, 'sum': 327907.0}, '5_posi_10393': {'bp': 99311.0, 'sum': 323592.0}, '4_posi_10435': {'bp': 98699.0, 'sum': 308826.0}, '12_posi_10812': {'bp': 93381.0, 'sum': 285378.0}, '7_posi_10666': {'bp': 92401.0, 'sum': 268743.0}, '2_posi_10854': {'bp': 87878.0, 'sum': 278243.0}, '1_posi_10898': {'bp': 87732.0, 'sum': 284565.0}, '5_posi_10917': {'bp': 84398.0, 'sum': 269430.0}, '14_posi_10790': {'bp': 100864.0, 'sum': 294346.0}, '3_posi_10581': {'bp': 98895.0, 'sum': 306052.0}, '12_posi_10516': {'bp': 98129.0, 'sum': 312358.0}, '18_posi_10747': {'bp': 95594.0, 'sum': 291465.0}, '2_posi_10771': {'bp': 77663.0, 'sum': 259983.0}, '2_posi_10688': {'bp': 98410.0, 'sum': 300562.0}, '1_posi_10540': {'bp': 84915.0, 'sum': 298804.0}, '14_posi_10874': {'bp': 84086.0, 'sum': 268019.0}, '19_posi_10665': {'bp': 83905.0, 'sum': 269864.0}, '18_posi_10919': {'bp': 98483.0, 'sum': 289969.0}, '9_posi_10666': {'bp': 93717.0, 'sum': 281427.0}, '19_posi_10497': {'bp': 93450.0, 'sum': 290086.0}, 'BLK01_10897': {'bp': 97707.0, 'sum': 343099.0}, 'BLK02_10688': {'bp': 85007.0, 'sum': 280269.0}, '19_posi_10791': {'bp': 84200.0, 'sum': 280357.0}, 'ProcedureBlank_10664': {'bp': 79578.0, 'sum': 271886.0}, '4_posi_10793': {'bp': 99412.0, 'sum': 266307.0}, 'ProcedureBlank_10751': {'bp': 95937.0, 'sum': 308769.0}, '14_posi_10622': {'bp': 89866.0, 'sum': 290155.0}, 'BLK02_10793': {'bp': 83260.0, 'sum': 257284.0}, 'BLK01_10747': {'bp': 95646.0, 'sum': 385135.0}}
COMMENT: RETENTION_TIME_STDEV 0.342
COMMENT: PRECURSOR_M/Z_RAW 112.086929
COMMENT: PRECURSOR_M/Z_STDEV 0.000034
COMMENT: PRECURSOR_IN_MS1 mz 112.086886; int 91.683; delta(ppm) 1.444804
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 144.113092; int 73.690; cor 0.807
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 153.113390; int 18.279; cor 0.706
COMMENT: PROPOSED_ION_FORM M+NH4; M+CH3OH+H; mz 127.086543; int 44.324; cor 0.766
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 153.113390; int 18.279; cor 0.706
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+CH3OH+H; mz 103.086576; int 123.539; cor 0.823
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 153.113390; int 18.279; cor 0.706
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.342; C5H9N3; [M+H]+; delta(ppm) -0.342097
COMMENT: PROPOSED_MF SevenGoldenRules 0.383; C5H6N2; [M+NH4]+; delta(ppm) -0.382763
COMMENT: PROPOSED_MF SevenGoldenRules 0.514; C3H6N2; [M+ACN+H]+; delta(ppm) -0.513896
COMMENT: PROPOSED_MF MS-FINDER 3.380; C5H9N3; [M+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF MS-FINDER 3.152; C5H6N2; [M+NH4]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF MS-FINDER 3.125; C3H6N2; [M+ACN+H]+; delta(ppm) 154779.544351
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.288; C5H9N3; [M+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.288; C5H6N2; [M+H3N+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.288; C3H6N2; [M+C2H3N+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.799; C2H7FN2O; [M+H3N+H]+; delta(ppm) -10.539883
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.003; C5H13O; [M+Na]+; delta(ppm) 87175.483111
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.818; C7H11O; [M+H]+; delta(ppm) -12.324259
COMMENT: PROPOSED_MF SIRIUS6_Sirius -14.754; CH9N3P; [M+H3N+H]+; delta(ppm) -3.103336
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H13O; [M+Na]+; delta(ppm) 87175.483111
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H9N3; [M+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H6N2; [M+H3N+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C3H6N2; [M+C2H3N+H]+; delta(ppm) -0.345635
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.707; NTYJJOPFIAHURM-UHFFFAOYSA-N; [M+H]+; Histamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.912; JXDFEQONERDKSS-UHFFFAOYSA-N; [M+H]+; Betazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.010; AGSPXMVUFBBBMO-UHFFFAOYSA-N; [M+ACN+H]+; Beta-Aminopropionitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.767; CAWHJQAVHZEVTJ-UHFFFAOYSA-N; [M+NH4]+; Methylpyrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.715; NUKYPUAOHBNCPY-UHFFFAOYSA-N; [M+NH4]+; 4-aminopyridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.670; AXPUQAAUHKSVKR-UHFFFAOYSA-N; [M+ACN+H]+; Acrylamidine;NSC 137783
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.662; JPPREFOETTUXDK-UHFFFAOYSA-N; [M+NH4]+; 1H-1,3-diazepine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.662; POXWDTQUDZUOGP-UHFFFAOYSA-N; [M+NH4]+; 1H-1,4-diazepine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.646; MTNDZQHUAFNZQY-UHFFFAOYSA-N; [M+ACN+H]+; imidazoline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.646; UAMZETBJZRERCQ-UHFFFAOYNA-N; [M+ACN+H]+; alpha-aminopropionitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.610; ICSNLGPSRYBMBD-UHFFFAOYSA-N; [M+NH4]+; 2-pyridylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.594; OAGOUCJGXNLJNL-UHFFFAOYSA-N; [M+ACN+H]+; dimethylcyanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.558; ZTOMUSMDRMJOTH-UHFFFAOYSA-N; [M+NH4]+; Glutaronitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.531; MCGBIXXDQFWVDW-UHFFFAOYSA-N; [M+ACN+H]+; 2-pyrazoline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.506; OSSNTDFYBPYIEC-UHFFFAOYSA-N; [M+NH4]+; 1-vinylimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.506; CUYKNJBYIJFRCU-UHFFFAOYSA-N; [M+NH4]+; UNPD83055
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.454; LRANPJDWHYRCER-UHFFFAOYSA-N; [M+NH4]+; 1H-diazepine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.427; BZWJDKJBAVXCMH-UHFFFAOYSA-N; [M+ACN+H]+; 1-diazopropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.427; DNXIASIHZYFFRO-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-3H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.427; PKNPFPQHDUSYLD-UHFFFAOYSA-N; [M+ACN+H]+; 3-iminoprop-1-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JXDFEQONERDKSS-UHFFFAOYSA-N; [M+H]+; Betazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JPPREFOETTUXDK-UHFFFAOYSA-N; [M+NH4]+; 1H-1,3-diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MCGBIXXDQFWVDW-UHFFFAOYSA-N; [M+ACN+H]+; 2-pyrazoline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NTYJJOPFIAHURM-UHFFFAOYSA-N; [M+H]+; Histamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.989; LRANPJDWHYRCER-UHFFFAOYSA-N; [M+NH4]+; 1H-diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.985; AXPUQAAUHKSVKR-UHFFFAOYSA-N; [M+ACN+H]+; Acrylamidine;NSC 137783
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.955; MTNDZQHUAFNZQY-UHFFFAOYSA-N; [M+ACN+H]+; imidazoline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.944; BZWJDKJBAVXCMH-UHFFFAOYSA-N; [M+ACN+H]+; 1-diazopropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; DNXIASIHZYFFRO-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-3H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.750; ICSNLGPSRYBMBD-UHFFFAOYSA-N; [M+NH4]+; 2-pyridylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.733; PKNPFPQHDUSYLD-UHFFFAOYSA-N; [M+ACN+H]+; 3-iminoprop-1-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.660; POXWDTQUDZUOGP-UHFFFAOYSA-N; [M+NH4]+; 1H-1,4-diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.642; NUKYPUAOHBNCPY-UHFFFAOYSA-N; [M+NH4]+; 4-aminopyridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.555; OAGOUCJGXNLJNL-UHFFFAOYSA-N; [M+ACN+H]+; dimethylcyanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.529; UAMZETBJZRERCQ-UHFFFAOYNA-N; [M+ACN+H]+; alpha-aminopropionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.492; CUYKNJBYIJFRCU-UHFFFAOYSA-N; [M+NH4]+; UNPD83055
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.492; CAWHJQAVHZEVTJ-UHFFFAOYSA-N; [M+NH4]+; Methylpyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.492; OSSNTDFYBPYIEC-UHFFFAOYSA-N; [M+NH4]+; 1-vinylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZTOMUSMDRMJOTH-UHFFFAOYSA-N; [M+NH4]+; Glutaronitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AGSPXMVUFBBBMO-UHFFFAOYSA-N; [M+ACN+H]+; Beta-Aminopropionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.904; NTYJJOPFIAHURM-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.330; MTNDZQHUAFNZQY-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.936; NUKYPUAOHBNCPY-UHFFFAOYSA-N; [M+NH4]+; pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.709; ICSNLGPSRYBMBD-UHFFFAOYSA-N; [M+NH4]+; pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.786; AGSPXMVUFBBBMO-UHFFFAOYSA-N; [M+ACN+H]+; 3-aminopropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.717; JXDFEQONERDKSS-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.639; MCGBIXXDQFWVDW-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.343; OSSNTDFYBPYIEC-UHFFFAOYSA-N; [M+NH4]+; 1-ethenylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.240; CAWHJQAVHZEVTJ-UHFFFAOYSA-N; [M+NH4]+; 2-methylpyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.129; MLMGJTAJUDSUKA-UHFFFAOYSA-N; [M+NH4]+; 2-ethenyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; LWBPCECUDKEKAD-UHFFFAOYSA-N; [M+NH4]+; pyridin-1-ium-1-ylazanide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.124; PZJGLURDALTFPQ-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; CUYKNJBYIJFRCU-UHFFFAOYSA-N; [M+NH4]+; pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; PLKGLZXMDLCSLY-UHFFFAOYSA-N; [M+NH4]+; 2-ethylpropanedinitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.074; YCIRHAGYEUJTFH-UHFFFAOYSA-N; [M+H]+; 2-imidazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; OAGOUCJGXNLJNL-UHFFFAOYSA-N; [M+ACN+H]+; dimethylcyanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; VKMQENXKRDPRHY-UHFFFAOYSA-N; [M+NH4]+; 2-(prop-2-ynylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; LVILGAOSPDLNRM-UHFFFAOYSA-N; [M+NH4]+; 4-methylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; UIWDESVQLUNCRV-UHFFFAOYSA-N; [M+H]+; 2-pyrazol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; OWMAUILZJRKPBN-UHFFFAOYSA-N; [M+NH4]+; 2-(azetidin-3-ylidene)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; IVZCHEJTIUBJPM-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; FAFFFBUYETUJAQ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; FUIJRCNCJHRODM-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; VYAFJWHVHCBQBJ-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-5-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; NJHKMGYIXSECKA-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1H-pyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; RPDQDVLOUJVEEX-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; KEQTWHPMSVAFDA-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dihydro-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; DEURIUYJZZLADZ-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; DJDBLBBSUAQYAA-UHFFFAOYSA-N; [M+H]+; piperazine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.988; IIRFPANPYNPFMC-BYPYZUCNSA-N; [M+H]+; (1S)-1-(1H-imidazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.988; FXNGQGIWLUWGBV-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.978; JYVPUGQZJRFFAF-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.977; TWGNOYAGHYUFFR-UHFFFAOYSA-N; [M+NH4]+; 5-methylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; GZJVUJXNJCCGEC-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; BCMJJXWXMZYZKN-UHFFFAOYSA-N; [M+NH4]+; 2,2-dimethylpropanedinitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.959; ROYYTESGJKJHTH-UHFFFAOYSA-N; [M+H]+; 2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; FXGJYEBAJZLAJX-UHFFFAOYSA-N; [M+H]+; piperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; DRYAADGKVSVPOP-UHFFFAOYSA-N; [M+H]+; 1,2,6-triazaspiro[2.5]oct-1-ene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; IOBYHAFGPGBUTE-UHFFFAOYSA-N; [M+H]+; 1,2,7-triazaspiro[2.5]oct-1-ene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; AXDGPQLEVYSXNL-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; FVSRJWMYUVOQNY-UHFFFAOYSA-N; [M+H]+; N-ethyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; YGRLFMMSIGPOOI-UHFFFAOYSA-N; [M+H]+; 1,5-dimethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; RDCODVKTTJWFAR-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; MXDRPNGTQDRKQM-UHFFFAOYSA-N; [M+NH4]+; 3-methylpyridazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; JUWWVCSNLLWQBL-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; LBNUVHAZHQZPHM-UHFFFAOYSA-N; [M+H]+; 1,4-dimethylimidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; RFDQETHJZZCIIU-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; AIKUBOPKWKZULG-UHFFFAOYSA-N; [M+NH4]+; 4-methylpyridazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; LNVWRBNPXCUYJI-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; RLXLWFPRNNKNMB-UHFFFAOYSA-N; [M+H]+; N,1-dimethylimidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; FSJOLBAFVKSQQJ-UHFFFAOYSA-N; [M+H]+; 2-ethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; KHWXEOSBFOWCJU-UHFFFAOYSA-N; [M+H]+; N,1-dimethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; UMRPGBHVNGOFMG-UHFFFAOYSA-N; [M+NH4]+; 4-ethenyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; VUVUCWXFEBDWEO-UHFFFAOYSA-N; [M+H]+; N,1-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; HENLKZLWIDJRSC-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.851; KFTRXTSNTQSGNE-UHFFFAOYSA-N; [M+H]+; (1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; DPRMXZQCCDEZAL-UHFFFAOYSA-N; [M+H]+; 1-ethylimidazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; MHQZDNQHLGFBRN-UHFFFAOYSA-N; [M+NH4]+; 5-ethenyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; KRWAHYMJTAHYQO-UHFFFAOYSA-N; [M+H]+; N,2-dimethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.840; SSXDUSOCSNXBPO-UHFFFAOYSA-N; [M+H]+; (1-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; AMBUTUSRGNEOAG-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; XNTFQMKXUFFUQO-UHFFFAOYSA-N; [M+H]+; (2-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; XPOZILPQFAIBOC-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-imidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; YPBTTWVBPFEPBE-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-pyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; YNTYLNZYNAMBNJ-UHFFFAOYSA-N; [M+H]+; (4-methyl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; PZSMLGOAJXSDMK-UHFFFAOYSA-N; [M+H]+; (1-methylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.820; PYAQTQXFMQWCHQ-UHFFFAOYSA-N; [M+H]+; (3-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.820; YSEAGFBRAQOCFM-UHFFFAOYSA-N; [M+H]+; (1-methylimidazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; JQZPHNUZEVAIJA-UHFFFAOYSA-N; [M+H]+; N,3-dimethylimidazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; AXLKRXWNAFFPDB-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; ZFDGMMZLXSFNFU-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; PVVRRUUMHFWFQV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(methylamino)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; JDYUVIGEKYZHLK-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-pyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.801; AJNQPSCMOSUVKK-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; WNGIFGULXSOHIO-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; CVGDNOXAJIGIFQ-UHFFFAOYSA-N; [M+H]+; (2-methyl-1H-imidazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; UAMZETBJZRERCQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-aminopropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; RHYMIFQNKOJHON-UHFFFAOYSA-N; [M+H]+; 4-ethyl-3-methyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; ZTOMUSMDRMJOTH-UHFFFAOYSA-N; [M+NH4]+; pentanedinitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.766; RDTUDLGSHURRHY-UHFFFAOYSA-N; [M+H]+; 1-propan-2-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; ZFWJVKLPEZPKNL-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.757; FLPWYJGTTKUYRV-UHFFFAOYSA-N; [M+H]+; 3-ethyl-4-methyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; UJAKGOWRYPECKS-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; JKSYHPUINDBWRF-UHFFFAOYSA-N; [M+H]+; 1,5-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.735; AHTVCDZZGBELIK-UHFFFAOYSA-N; [M+H]+; 2,4-dimethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.729; GHXKHKWEVUKGHR-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylimidazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.716; LWTIGYSPAXKMDG-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dihydro-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.715; CYCYZHMUOSKYBG-UHFFFAOYSA-N; [M+ACN+H]+; prop-2-ynylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; LNJMHEJAYSYZKK-UHFFFAOYSA-N; [M+NH4]+; 2-methylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.633; NWHSSMRWECHZEP-UHFFFAOYSA-N; [M+NH4]+; 1-ethenylpyrazole
COMMENT: CONFIDENCE Level 5: Exact mass of interest 112.086885; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 21.415
MS$FOCUSED_ION: PRECURSOR_M/Z 112.086885
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03xr-6900000000-be6787676194715d1e3c
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  69.0447444 734.3131 ? 69.045370 0.3331 58.74 0.5600 120
  69.0699046 138.8816 ? 69.070530 1.1872 23.56 0.1219 120
  70.0732405 221.0243 ? 70.073860 0.7421 31.53 0.3222 120
  71.0603618 44.6888 ? 71.060975 1.7591 11.82 0.1111 116
  83.0604013 38.7036 ? 83.060905 2.0106 9.99 0.0008 92
  112.0393948 46.1058 ? 112.039600 1.9993 12.45 -0.0242 103
  112.0506650 117.5859 ? 112.050870 1.9009 20.62 0.1080 120
  112.0754052 74.3743 ? 112.075610 2.2663 14.85 0.1884 119
  112.0870154 999.0000 ? 112.087220 0.9011 0.00 1.0000 120
  112.0951054 262.6867 ? 112.095310 0.7761 92.17 0.1902 120
  113.0345760 157.3108 ? 113.034770 1.3978 26.49 0.2065 120
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  69.044744 734.31 734
  69.069905 138.88 138
  70.073241 221.02 221
  71.060362 44.69 44
  83.060401 38.70 38
  112.039395 46.11 46
  112.050665 117.59 117
  112.075405 74.37 74
  112.087015 999.00 999
  112.095105 262.69 262
  113.034576 157.31 157
//
